Nova Patents
AP1739A

Azaindoles

Abstract

The invention is directed to physiologically active compounds of general formula (I): and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

Every citation, both ways

Citations
DocumentRelationOfficeCited during
EP1086950A1CitesEuropean Patent Office (EPO)Search report
WO9920624A1CitesWorld Intellectual Property Organization (WIPO)Search report